{"id":340930,"date":"2026-11-05T16:27:12","date_gmt":"2026-11-05T10:57:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/suven-life-sciences-q2-results-fy27-loss-107-crore\/"},"modified":"2026-11-05T16:27:12","modified_gmt":"2026-11-05T10:57:12","slug":"suven-life-sciences-q2-results-fy27-loss-107-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/suven-life-sciences-q2-results-fy27-loss-107-crore\/","title":{"rendered":"Suven Life Sciences Q2 Results FY27: Net Loss Rs 106.94 Cr, Revenue Rs 1.20 Cr, Operating Loss Rs 110.92 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Suven Life Sciences Q2 Results FY27 were declared on 5 November 2026 on a Consolidated basis. The quarterly results show revenue of Rs 1.20 Cr, up 30.43% year on year from Rs 0.92 Cr. Net loss was Rs 106.94 Cr against a net loss of Rs 77.31 Cr a year earlier, a YoY change of -38.33% as reported. Operating Profit was a loss of Rs 110.92 Cr against a loss of Rs 79.77 Cr.<\/p>\n<\/div>\n

Suven Life Sciences Ltd<\/a> (SUVEN) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought consolidated results with revenue of Rs 1.20 Cr and a net loss of Rs 106.94 Cr, and Suven Life Sciences Q2 Results FY27 are measured against the same quarter a year earlier. Revenue is higher on that comparison, while the net loss is larger.<\/p>\n

This results analysis covers the financial highlights, business drivers, outlook and risks behind the Suven Life Sciences Q2 Results. The Financial Highlights table that follows places the Consolidated figures beside the year-earlier quarter, so every reported number is visible before the discussion starts.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n